Cardiomyopathy: Difference between revisions
No edit summary |
|||
Line 10: | Line 10: | ||
{{CMG}}; {{AE}} {{CZ}}, {{RT}} | {{CMG}}; {{AE}} {{CZ}}, {{RT}} | ||
{{SK}} Myocardiopathy; cardiac muscle disease | {{SK}} Myocardiopathy; cardiac muscle disease; heart muscle disease. | ||
== [[Cardiomyopathy overview|Overview]] == | == [[Cardiomyopathy overview|Overview]] == |
Revision as of 15:29, 4 January 2013
For patient information click here
Cardiomyopathy | |
Opened left ventricle of heart shows a thickened, dilated left ventricle with subendocardial fibrosis manifested as increased whiteness of endocardium {Autopsy findings}. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Guidelines |
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
Case Studies |
Cardiomyopathy On the Web |
American Roentgen Ray Society Images of Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S. [3]
Synonyms and keywords: Myocardiopathy; cardiac muscle disease; heart muscle disease.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
de:Kardiomyopathie nl:Cardiomyopathie no:Kardiomyopati simple:Cardiomyopathy sr:Кардиомиопатија sv:Hjärtmuskelsjukdom